4-Methylcyclohexanamine

Catalog No.: 
ACRQOL817
CAS No.: 
6321-23-9
Molecular Formula: 
C7H15N
Molecular Weight: 
113.20
4-Methylcyclohexanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$59.00In stockInquiry
25g98%$206.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methylcyclohexanamine
IUPAC Name4-methylcyclohexan-1-amine
MDL No.MFCD00001495
Molecular FormulaC7H15N
Molecular Weight113.20
SMILESNC1CCC(C)CC1
InChI KeyKSMVBYPXNKCPAJ-UHFFFAOYSA-N
SynonymSC 5233 | UNII-M9AY9BSI41 | A5111 | Cyclohexylamine, 4-methyl- | 4-Methylcyclohexylamine | 4-Methyl-cyclohexylamine | NSC 11037 | p-Aminocyclohexylmethane | Q27453111 | 4-Methylcyclohexylamine, cis- | 4-Methylcyclohexylamine, trans- | BB 0259385 | CIS-4-M
CAS No.6321-23-9
PubChem CID80604

Safety Data

Pictogram
CorrosiveFlammable
Signal Word
Danger
Hazard Statement(s)
H225-H314
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACRQOL817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHGDK487 route compound structure diagram
    ACHGDK4874994-13-2In Stock
  2. Then
  3. ACRQOL817 route product structure diagram
    ACRQOL8176321-23-9In Stock
Inquiry

2. ACRQOL817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACRQOL817 route product structure diagram
    ACRQOL8176321-23-9In Stock
Inquiry

3. ACRQOL817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACRQOL817 route product structure diagram
    ACRQOL8176321-23-9In Stock
Inquiry

Comments (0)